Immuno-Biological Laboratories Co., Ltd. (JASDAQ:4570) announced a private placement with Merrill Lynch Japan Securities Co., Ltd., Investment Arm, of 70,000 units of 1st round warrants at ¥210 per unit for gross proceeds of ¥14,700,000 on June 14, 2013. The transaction has been approved at its board of directors' meeting. The warrants are exercisable into 70,000 shares of the company at an initial exercise price of ¥19,530. The subscription date is July 4, 2013, and allocation and payment date is July 5, 2013. The warrants exercise period is from July 8, 2013 to July 7, 2015. The company will incur various expenses for the issuance including attorney fee, accountant fee, judicial clerk fee, trust bank expenses and so on.

On July 5, 2013, Immuno-Biological Laboratories Co., Ltd. closed the transaction.